News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Incyte Corporation Announces First Quarter Financial Results And Provides Update On Drug Discovery And Development Programs
May 4, 2006
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
WILMINGTON, Del.--(BUSINESS WIRE)--May 4, 2006--Incyte Corporation (Nasdaq:INCY - News) today announced its financial results for the first quarter 2006 and reported on the company's most advanced drug discovery and development programs.
Twitter
LinkedIn
Facebook
Email
Print
Earnings
Incyte
MORE ON THIS TOPIC
Layoff Tracker
GSK Puts up to 350 US, UK Jobs on the Chopping Block
February 3, 2026
·
49 min read
·
BioSpace Editorial Staff
Rare diseases
GSK Hands RNA Editor Back to Wave After Underwhelming Early AATD Data
February 2, 2026
·
2 min read
·
Tristan Manalac
Manufacturing
Eli Lilly Commits $3.5B To Build Injectable Obesity Drug Plant in PA
February 2, 2026
·
2 min read
·
Nick Paul Taylor
Autoimmune disease
Amgen Ends Autoimmune Alliance With Kyowa Kirin Amid Safety, Efficacy Questions
February 2, 2026
·
2 min read
·
Tristan Manalac